Clinical trials
Completed Breast Neoplasms trials in Estonia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 6 |
| Sanofi | 2 |
| AbbVie | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
| Pierre Fabre Medicament | 1 |
| Prestige Biopharma Limited | 1 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 16 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.